title: Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.
abstract: Mucin1 (MUC1) is expressed ubiquitously on breast cancer cells and is a potential target for the generation of cytotoxic T cells for vaccination against breast cancer. Thus far studies of the immunogenicity of MUC1 have used peptides from the variable number of tandem repeat (VNTR); mice so immunised can generate strong cellular and antibody responses to the VNTR of human MUC1. We now demonstrate that significant CTL and CTLp can be induced to other regions of MUC1. Using the whole native MUC1 molecule, the human milk fat globule membrane antigen (HMFG) linked to mannan, cytotoxic T cell precursors (CTLp) can be generated in BALB/c, C57BL/6, transgenic HLA-A*0201/K(b) and double transgenic HLA-A*0201/K(b)xhuman MUC1 (A2 K(b)MUC1) mice. By immunising with HMFG and testing selectively on (a) extracellular (non-VNTR); (b) VNTR and (c) intracellular peptides, it was shown that all three regions generated effective CTL. Further, the CTL responses to non-VNTR peptides were as strong as those generated to the VNTR. Epitope prediction algorithms were not particularly helpful to describe CTL epitopes: overlapping peptides had to be synthesised and tested to find the epitopes. Thus, for CTL generation, the whole HMFG molecule is a powerful immunogen when linked to mannan, especially as multiple peptide epitopes for presentation by many Class I molecules are contained within the one molecule. Furthermore, Class I restricted MUC1 CTL were generated in double transgenic A2 K(b)MUC1 mice by immunising with mannan-native mucin (HMFG), suggesting that tolerance to MUC1 can be overcome with mannan-HMFG.
authors.affiliation: The Austin Research Institute, Studley Rd, Heidelberg, Australia. g.pietersz@ari.unimelb.edu.au
authors.forename: G A
authors.initials: GA
authors.lastname: Pietersz
authors.forename: W
authors.initials: W
authors.lastname: Li
authors.forename: C
authors.initials: C
authors.lastname: Osinski
authors.forename: V
authors.initials: V
authors.lastname: Apostolopoulos
authors.forename: I F
authors.initials: IF
authors.lastname: McKenzie
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D019496:Cancer Vaccines / Q000276:immunology; D000939:Epitopes / Q000737:chemistry / Q000235:genetics; D005260:Female; D006017:Glycolipids / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D006023:Glycoproteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D006183:H-2 Antigens; D006801:Humans; D007114:Immunization; D066292:Lipid Droplets; D008351:Mannans / Q000737:chemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D018598:Minisatellite Repeats; D008969:Molecular Sequence Data; D018396:Mucin-1 / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D010446:Peptide Fragments / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D020080:Tandem Repeat Sequences
chemical_list: D019496:Cancer Vaccines; D000939:Epitopes; D006017:Glycolipids; D006023:Glycoproteins; D006183:H-2 Antigens; C116055:MUC1 tandem repeat peptide; D008351:Mannans; D018396:Mucin-1; D010446:Peptide Fragments; C110367:milk fat globule